Atlas Trials

Study of Euthyroid Hypothyroxinemia in Metastatic Breast Carcinoma

Clinical trial NCT03787303 · TERMINATED

Trial details

NCT number
NCT03787303
Sponsor
Aultman Health Foundation
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Breast CancerThyroid Dysfunction
Start date
2019-03-01
Primary completion
2022-03-09
Enrollment
7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.